Stimuli-responsive fluorogenic prodrugs of potent inhibitors targeting overexpressed metabolic enzymes in cancer

Pallavi Barman, Nikita Pal, Rahul Kesarwani and Krishna P. Bhabak

Chem. Commun., 2026, 62, 11014
DOI: 10.1039/D6CC00654J

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing and Tengchuan Jin

iNew Medicine, 2026
DOI: 10.1002/inm3.70033

Precision Chemistry–Guided Peptide and Protein Self‐Assembly

Hamdi Nsairat

Peptide Science, 2026, 118
DOI: 10.1002/pep2.70033

Unveiling the Role of Glutathione S-transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications

Manisha Nigam, Shivangi Kukreti, Sudarshan Singh and Abhay Prakash Mishra

ACS Pharmacol. Transl. Sci., 2026, 9, 1285
DOI: 10.1021/acsptsci.6c00043

Uncovering the Tumorigenic Blueprint of PFOS and PFOA Through Multi-Organ Transcriptomic Analysis of Biomarkers, Mechanisms, and Therapeutic Targets

Krisha Mathur, Aleezah Khaliq, Stephanie Park, Nathan Chu, Vaishnavi M. Burra, Norah Kanukolanu, Ellen Costello and Sivanesan Dakshanamurthy

CIMB, 2025, 47, 763
DOI: 10.3390/cimb47090763

Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells

Geovana Guedes Silvestre, Thalisson Amorim de Souza, Alan Ferreira Alves, Valeria Dutan‐Patiño, Jean‐Michel Huvelin, Mathilde Gourdel, Mikael Croyal, Samuel Cibulski, Demetrius Antonio Machado de Araújo, Marcus Tullius Scotti, Josean Fechine Tavares, Angela Tesse, El‐Hassan Nazih and Marianna Vieira Sobral

ChemMedChem, 2026, 21
DOI: 10.1002/cmdc.70308